Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 2.13 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 2.62 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 2.81 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 2.0 | BCD100624C013 | 2.18 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 3.16 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 3.19 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 4.75 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 2.95 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 0.0 | BCD100624C001 | 1.66 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 0.5 | BCD100624C003 | 1.81 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 1.0 | BCD100624C007 | 2.27 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 2.0 | BCD100624C011 | 2.43 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 4.0 | BCD100624C015 | 2.9 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 8.0 | BCD100624C019 | 3.21 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 12.0 | BCD100624C023 | 2.8 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 24.0 | BCD100624C027 | 3.37 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 2.32 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | 2.01 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 2.78 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 1.98 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 2.88 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 4.09 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 2.83 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 0.5 | BCD100624C004 | 3.24 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 1.0 | BCD100624C008 | 3.56 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 2.0 | BCD100624C012 | 2.74 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 4.0 | BCD100624C016 | 3.04 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 8.0 | BCD100624C020 | 3.05 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 12.0 | BCD100624C024 | 3.54 | pmol/ug DNA |
| LMFA01030159 | 11,14,17-eicosatrienoic acid | 25OH-Chol | 24.0 | BCD100624C028 | 4.49 | pmol/ug DNA |